These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8966205)

  • 1. Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies.
    Saitta A; Bonaiuto M; Giordano G; Saitta MN; Castaldo M; Cinquegrani M; Squadrito G; Canale P; Altavilla D; Campo GM; Caputi AP; Squadrito F
    Pharmacology; 1996 Jan; 52(1):8-15. PubMed ID: 8966205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.
    Lidbury PS; Cirillo R; Vane JR
    Br J Pharmacol; 1993 Sep; 110(1):275-80. PubMed ID: 8220889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P; Migliacci R; Di Sante G; Nenci GG;
    Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat.
    Fries W; Mazzon E; Sturiale S; Giofré MR; Lo Presti MA; Cuzzocrea S; Campo GM; Caputi AP; Longo G; Sturniolo GC
    Life Sci; 2004 Apr; 74(22):2749-56. PubMed ID: 15043989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation, ATP release and cytoplasmic Ca2+ movement: the effects of cloricromene.
    Davì G; Giammaresi C; Catalano I; Calà A; Prosdocimi M; Alvino S; Piva S; Notarbartolo A
    Thromb Res; 1994 Oct; 76(2):121-31. PubMed ID: 7863464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal and systemic pharmacokinetics of the anti-inflammatory drug cloricromene following oral administration in the rat and rabbit.
    Bucolo C; Maugeri F; Maltese A; Ward KW
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):257-63. PubMed ID: 17593009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloricromene effect on the enzyme activities of the tryptophan-nicotinic acid pathway in diabetic/hyperlipidemic rabbits.
    Ragazzi E; Costa CV; Comai S; Bertazzo A; Caparrotta L; Allegri G
    Life Sci; 2006 Jan; 78(8):785-94. PubMed ID: 16126232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury.
    Calapai G; Squadrito F; Rizzo A; Marciano MC; Campo GM; Caputi AP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):209-15. PubMed ID: 7770103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene.
    Bucolo C; Maltese A; Maugeri F; Busà B; Puglisi G; Pignatello R
    J Pharm Pharmacol; 2004 Jul; 56(7):841-6. PubMed ID: 15233861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloricromene, a coumarine derivative, protects against lethal endotoxin shock in rats.
    Squadrito F; Altavilla D; Campo GM; Calapai G; Ioculano M; Zingarelli B; Saitta A; Prosdocimi M; Caputi AP
    Eur J Pharmacol; 1992 Jan; 210(2):107-13. PubMed ID: 1601052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endothelin-1 and sarafotoxin S6b on regional hemodynamics in the conscious dog.
    Leadley RJ; Zhu JL; Goetz KL
    Am J Physiol; 1991 Jun; 260(6 Pt 2):R1210-7. PubMed ID: 2058748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cloricromene during ischemia and reperfusion of rabbit hindlimb: evidence for an involvement of leukocytes in reperfusion-mediated tissue and vascular injury.
    Cirillo R; Salvatico E; Aliev G; Prosdocimi M
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):969-75. PubMed ID: 1282601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of myocardial damage by cloricromene during ischemia-reperfusion in the rabbit.
    Milei J; Llesuy S; Ferreira R; Grana D; Prosdocimi M; Boveris A
    Cardioscience; 1992 Jun; 3(2):97-105. PubMed ID: 1643242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of polymorphonuclear leucocyte functions by cloricromene.
    Zatta A; Bevilacqua C
    Pharmacol Res; 1999 Dec; 40(6):525-33. PubMed ID: 10660952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.
    Sturniolo R; Squadrito F; Altavilla D; Trimarchi GR; Prosdocimi M; Caputi AP
    Circ Shock; 1989 Jul; 28(3):267-77. PubMed ID: 2766481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The exercise-induced increase in plasma levels of endothelin-1 is enhanced in patients with atherosclerotic coronary artery disease. Modulation by pentaerithrityltetranitrat (PETN).
    Predel HG; Knigge H; Prinz U; Stalleicken D; Kramer HJ; Rost RE
    Agents Actions Suppl; 1995; 45():219-25. PubMed ID: 7717184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the coumarin derivative cloricromene acid in rabbit plasma and platelets.
    Mariot R; Zangirolami L; Bellato P; Chen S; Pieraccini G; Moneti G
    J Chromatogr; 1992 Apr; 576(1):143-8. PubMed ID: 1500448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloricromene antagonizes antidipsogenic effects induced by endotoxin, but not by TNF alpha, in the rat.
    Calapai G; Mazzaglia G; Marciano MC; Squadrito F; Altavilla D; Zingarelli B; Prosdocimi M; Caputi AP
    Life Sci; 1992; 51(26):2041-8. PubMed ID: 1474860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postischemic hyperemia in subjects with lower limbs obstructive arteriopathy: role of PGI2 and endothelin.
    Pancera P; Minuz P; Rossi L; Ribul M; Arosio E; Lechi A
    Angiology; 1997 Feb; 48(2):149-55. PubMed ID: 9040270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.